image
Healthcare - Medical - Instruments & Supplies - NASDAQ - BE
$ 5.94
-1.57 %
$ 204 M
Market Cap
-2.88
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one NYXH stock under the worst case scenario is HIDDEN Compared to the current market price of 5.94 USD, Nyxoah S.A. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one NYXH stock under the base case scenario is HIDDEN Compared to the current market price of 5.94 USD, Nyxoah S.A. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one NYXH stock under the best case scenario is HIDDEN Compared to the current market price of 5.94 USD, Nyxoah S.A. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart NYXH

image
$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0$5.0$5.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
4.52 M REVENUE
3.98%
-58.8 M OPERATING INCOME
-30.39%
-59.2 M NET INCOME
-32.65%
-49.2 M OPERATING CASH FLOW
-9.93%
-16.3 M INVESTING CASH FLOW
-51.00%
77.4 M FINANCING CASH FLOW
359.36%
1.26 M REVENUE
-0.24%
-18.3 M OPERATING INCOME
-22.24%
-15.1 M NET INCOME
11.66%
-12.2 M OPERATING CASH FLOW
9.25%
-6.58 M INVESTING CASH FLOW
-113.08%
23.4 M FINANCING CASH FLOW
157.35%
Balance Sheet Nyxoah S.A.
image
Current Assets 98.1 M
Cash & Short-Term Investments 85.6 M
Receivables 3.38 M
Other Current Assets 9.15 M
Non-Current Assets 60.3 M
Long-Term Investments 0
PP&E 8.25 M
Other Non-Current Assets 52.1 M
54.01 %5.77 %5.21 %32.87 %Total Assets$158.4m
Current Liabilities 21.5 M
Accounts Payable 3.75 M
Short-Term Debt 1.37 M
Other Current Liabilities 16.4 M
Non-Current Liabilities 23.6 M
Long-Term Debt 21.3 M
Other Non-Current Liabilities 2.34 M
8.30 %3.03 %36.35 %47.15 %5.17 %Total Liabilities$45.2m
EFFICIENCY
Earnings Waterfall Nyxoah S.A.
image
Revenue 4.52 M
Cost Of Revenue 1.55 M
Gross Profit 2.97 M
Operating Expenses 61.8 M
Operating Income -58.8 M
Other Expenses 427 K
Net Income -59.2 M
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)5m(2m)3m(62m)(59m)(427k)(59m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
65.67% GROSS MARGIN
65.67%
-1300.80% OPERATING MARGIN
-1300.80%
-1310.24% NET MARGIN
-1310.24%
-52.30% ROE
-52.30%
-37.40% ROA
-37.40%
-44.65% ROIC
-44.65%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Nyxoah S.A.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -59.2 M
Depreciation & Amortization 764 K
Capital Expenditures -6.07 M
Stock-Based Compensation 0
Change in Working Capital 0
Others 15.1 M
Free Cash Flow -55.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Nyxoah S.A.
image
Wall Street analysts predict an average 1-year price target for NYXH of $16.8 , with forecasts ranging from a low of $15 to a high of $18 .
NYXH Lowest Price Target Wall Street Target
15 USD 152.53%
NYXH Average Price Target Wall Street Target
16.8 USD 181.99%
NYXH Highest Price Target Wall Street Target
18 USD 203.03%
Price
Max Price Target
Min Price Target
Average Price Target
18181616141412121010886644Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 8
6. Ownership
Insider Ownership Nyxoah S.A.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / April 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 1 week ago
Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ:NYXH). accessnewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH NEW YORK CITY, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / April 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
Conditional Issuance of Shares INSIDE INFORMATION REGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), today announced a conditional issuance of up to 5 million ordinary shares under its existing at-the-market equity offering programs (the “ATM”). This brings the aggregate number of ordinary shares that can be sold and issued under the Company's ATM to 5,662,694 (the “ATM Shares”), which includes 662,694 shares that are still available from the conditional issuance of shares under the ATM decided upon on December 22, 2022. globenewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. ("Nyxoah" or "the Company") (NASDAQ:NYXH). accessnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). prnewswire.com - 2 weeks ago
8. Profile Summary

Nyxoah S.A. NYXH

image
COUNTRY BE
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 204 M
Dividend Yield 0.00%
Description Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Contact Rue Edouard Belin 12, Mont-Saint-Guibert, 1435 https://www.nyxoah.com
IPO Date April 28, 2021
Employees 183
Officers Mr. Loic Moreau President of International Mr. Robert Taub MBA Co-Founder & Chairman Mr. Olivier Taelman Chief Executive Officer & Executive Director Mr. Bruno Onkelinx Chief Technical Officer Ms. An Moonen General Counsel Mr. Remi Renard Chief of Staff Mr. John Landry Chief Financial Officer Ms. Maggie McGowan Chief HR Officer Mikaela Kirkwood Corporate Communication & Investor Relations Manager Mr. Jeyakumar Subbaroyan Chief Clinical Officer